Capital Research Global Investors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3M | Buy |
776,953
+6,185
| +0.8% | +$432K | 0.01% | 340 |
|
|
2025
Q1 | $56.7M | Buy |
770,768
+3,040
| +0.4% | +$223K | 0.01% | 347 |
|
|
2024
Q4 | $50.3M | Sell |
767,728
-312,490
| -29% | -$20.5M | 0.01% | 357 |
|
|
2024
Q3 | $84.2M | Sell |
1,080,218
-314,805
| -23% | -$24.5M | 0.02% | 298 |
|
|
2024
Q2 | $109M | Buy |
1,395,023
+4,366
| +0.3% | +$341K | 0.02% | 266 |
|
|
2024
Q1 | $94.2M | Sell |
1,390,657
-346,008
| -20% | -$23.4M | 0.02% | 292 |
|
|
2023
Q4 | $117M | Buy |
1,736,665
+220,514
| +15% | +$14.9M | 0.03% | 266 |
|
|
2023
Q3 | $103M | Buy |
1,516,151
+378,722
| +33% | +$25.6M | 0.03% | 272 |
|
|
2023
Q2 | $81.4M | Buy |
1,137,429
+101,975
| +10% | +$7.3M | 0.02% | 295 |
|
|
2023
Q1 | $71.9M | Buy |
+1,035,454
| New | +$71.9M | 0.02% | 302 |
|
|
2013
Q4 | – | Sell |
-2,342,000
| Closed | -$60.8M | – | 432 |
|
|
2013
Q3 | $60.8M | Buy |
+2,342,000
| New | +$60.8M | 0.02% | 318 |
|